溶解性 | DMSO 20 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
存贮条件 | 储存温度-20°C |
备注 | Golvatinib (E7050) is a dual c-Met and VEGFR-2 inhibitor with IC50 of 14 nM and 16 nM, does not inhibit bFGF-stimulated HUVEC growth (up to 1000 nM). Phase 1/2. |
生化机理 | E-7050 is hepatocyte growth factor receptors (HGFR). |
别名 | 1,1-Cyclopropanedicarboxamide, N-[2-fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-;1,1-Cyclopropanedicarboxamide, N-[2-fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)- |
Golvatinib (E7050),抑制剂
Golvatinib (E7050) (订货以英文为准)
编号:E126304
CAS号:928037-13-2
分子式:C33H37F2N7O4
分子量:633.69
产品名称 | Golvatinib (E7050) |
中文名称 | Golvatinib (E7050),抑制剂 |
CAS号 | 928037-13-2 |
分子式(M.F.) | C33H37F2N7O4 |
分子量(M.W.) | 633.69 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品